Dr. Rule On Patients With P53-Mutated Mcl

Dr. Rule on Patients With p53-Mutated MCL

Dr. Rule on Treatment Approaches for Patients With p53-Mutated MCL

Dr. Shah on Treatment of Patients with P53-Mutated MCL

Dr. Elhassadi Discusses the Outlook of Patients With p53-Mutated MCL

Dr. Shah Discusses P53-Mutated Mantle Cell Lymphoma

Dr. Rule on Treatment of Young, Fit Patients With MCL

Advice for Treating Patients With MCL

Targeted Oncology

Dr. Rule on Searching for a Biomarker Indicating Indolent MCL

Dr. Eskelund on Outcomes of TP53-Mutated MCL

Challenges in treating patients with TP53-mutated MCL & promising novel therapies being explored

VJHemOnc – Video Journal of Hematology & HemOnc

The impact of TP53 mutation on treatment approaches in MCL

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Landen Discusses p53 Mutations in Ovarian Cancer

CAR-T therapy for high-risk MCL patients

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Rule on Watching and Waiting Approach For MCL Subset

Dr. Rule on the Future Treatment Paradigm in MCL

Treatment approaches for patients with TP53-mutated MCL

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Eskelund on Study of TP53 Mutations in Mantle Cell Lymphoma

Dr. Rule on Potential for CAR T-Cell Therapy in MCL

Dr. Rule on the Role of BTK Inhibitors in MCL

Dr. Rule on the Treatment Paradigm in MCL